Institutional Capital Portfolio holdings
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$258M |
| 2 |
CVS Health
CVS
|
+$230M |
| 3 |
Labcorp
LH
|
+$205M |
| 4 |
RTX Corp
RTX
|
+$181M |
| 5 |
Honeywell
HON
|
+$84.1M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
+$217M |
| 2 |
Northern Trust
NTRS
|
+$175M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$169M |
| 4 |
Pentair
PNR
|
+$161M |
| 5 |
Goldman Sachs
GS
|
+$127M |
Sector Composition
| 1 | Healthcare | 22.09% |
| 2 | Communication Services | 19.08% |
| 3 | Financials | 18.15% |
| 4 | Technology | 16.59% |
| 5 | Industrials | 10.43% |
Similar funds
Institutional Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Institutional Capital held 57 positions worth $7.26B, down 11% from $8.17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Institutional Capital withdrew a net $857M in Q3 2016, closing 4 positions and reducing 33 holdings. Its most notable exit was Northern Trust, an estimated $175M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Institutional Capital opened a new position in Alphabet (Google) Class C worth $264M.
- Institutional Capital's largest Q3 2016 buy was Alphabet (Google) Class C: 6,800,820 shares worth $264M.
- Institutional Capital added most to Honeywell in Q3 2016, an estimated $84.1M increase.
- Institutional Capital's biggest Q3 2016 reduction was Teva Pharmaceuticals, cutting an estimated $217M.
- Institutional Capital fully exited Northern Trust in Q3 2016, selling an estimated $175M.
- Institutional Capital's ten largest holdings make up 40% of its $7.26B portfolio in Q3 2016.
- Institutional Capital opened 8 new positions and closed 4 in Q3 2016.
- Institutional Capital's portfolio value fell 11% quarter-over-quarter to $7.26B.
Based on Institutional Capital's 13F filing for Q3 2016, filed 10 Nov 2016.